Dozens of colleges are instituting stricter rules for diagnosing and medicating attention deficit hyperactivity disorder, The New York Times reports.
Category results for "Prescription Drugs"
Certain genetic variants in babies who were exposed to opioids in the womb may protect them, leading to shorter hospital stays and less treatment, according to a new study.
The Medical Board of California has voted to support measures designed to fight prescription drug abuse, the Los Angeles Times reports. The board refused to transfer its investigators looking into physician misconduct in prescription drug abuse cases to the state Attorney General’s office.
Young adults who had participated in a community-based prevention program in middle school reduced their prescription drug misuse up to 65 percent, a new study finds.
Three federal government agencies are urging employees to dispose of unwanted or expired drugs, as part of National Prescription Drug “Take-Back” Day on Saturday.
One-fourth of teens have misused or abused a prescription drug at least once in their lifetime, a 33 percent increase over the last five years, a new study finds. One in eight teens say they have taken Ritalin or Adderall when it was not prescribed for them, according to the study by The Partnership at Drugfree.org and MetLife Foundation.
Some pain doctors say they are concerned the Food and Drug Administration’s decision earlier this week not to approve generic versions of the original version of OxyContin could lead to less effective drugs that are potentially addictive, NPR reports.
The Food and Drug Administration announced Tuesday it will not approve any generic versions of the original form of OxyContin. The move is aimed at preventing prescription drug abuse, Reuters reports.
As prescription painkillers become more difficult to obtain and abuse, a growing number of people addicted to these drugs are switching to heroin, USA Today reports. The trend is increasingly being seen in the suburbs.
Generic drug makers are waiting for the Food and Drug Administration to decide whether they must make tamper-resistant forms of OxyContin, or if they can produce the original version, The Wall Street Journal reports. OxyContin’s first patent expires Tuesday.